Game not over for J&J: Johnson & Johnson may still beat rival in fight for Guidant
Boston Scientific Corp. earned instant front-runner status in the bidding war for Guidant Corp. when it unveiled a $25 billion offer on Dec. 5 that trumped a Johnson & Johnson proposal by more than $3 billion. However, market watchers say, J&J can regain the lead simply by counterpunching with a comparable offer. They say the immense New Jersey-based conglomerate offers more stability and is the better long-term option for Guidant shareholders who want to hold onto the buyer’s stock after…